Σύγκριση μεθόδων

	Chronic Otitis Media Outcome Test-15	Απογραφή Ωφέλειας της Γλασκώβης
Πεδίο	Ωτορινολαρυγγολογία	Ωτορινολαρυγγολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	2016	1996
Δημιουργός	Anne G.M. Schilder and colleagues (COMOT working group)	Karol Robinson, Sophia Gatehouse, and Gordon G. Browning
Τύπος	Self-report	Self-report
Θεμελιώδης πηγή	Schilder, A. G., Su, M. P., Blackshaw, H., Lustig, L. R., & O'Donoghue, G. M. (2016). Chronic Otitis Media Outcome Test-15 (COMOT-15): Development and psychometric evaluation. Otology & Neurotology, 37(9), 1314-1320.	Robinson, K., Gatehouse, S., & Browning, G. G. (1996). Measuring patient benefit from otorhinolaryngological surgery and treatment. Annals of Otology, Rhinology & Laryngology, 105(6), 415-422.
Εναλλακτικές ονομασίες	COMOT-15	GBI
Συναφείς	3	3
Σύνοψη	The Chronic Otitis Media Outcome Test-15 (COMOT-15) is a 15-item patient-reported outcome measure specifically designed to assess the burden and impact of chronic otitis media on health-related quality of life. Developed by Schilder and colleagues (2016), the COMOT-15 measures symptoms (ear discharge, hearing loss, ear pain), hearing function, and psychosocial effects of chronic ear disease. It is the recommended core outcome set for clinical trials and quality improvement programs evaluating chronic otitis media treatment.	The Glasgow Benefit Inventory (GBI) is an 18-item self-report questionnaire designed to measure change in health status and general well-being resulting from otolaryngologic intervention (surgery, medical treatment). Unlike generic health-related quality-of-life measures, the GBI is disease-specific, asking patients to compare their post-intervention status to their pre-intervention baseline. Developed by Robinson, Gatehouse, and Browning in 1996, the GBI has become the standard outcome measure for evaluating benefit from ear, nose, and throat surgery and treatment.